Navigation Links
Paoli Hospital Pioneers New Treatment for Uterine Fibroids and Malformations
Date:6/27/2011

PAOLI, Pa., June 27, 2011 /PRNewswire/ -- A radiologic technology, which functions like a 'human GPS system,' and provides more precise results while using less radiation, is being used to treat patients with symptomatic uterine fibroids exclusively at Paoli Hospital. Dr. Atul Gupta, director of interventional radiology, is treating patients as part of a first-ever clinical trial.

This 3-D imaging system, used by Dr. Gupta, allows procedures to be done with more precision, less radiation, less time and less X-ray dye than previously on 2-D machines. In collaboration with Philips, a leading manufacturer of medical devices, Dr. Gupta has been pioneering a variety of applications for the technology at Paoli Hospital for the past five years.

Representatives from leading healthcare institutions from across the country have visited Paoli Hospital to observe the procedure.  Paoli Hospital, under the auspices of Main Line Health, is the only hospital in the United States to offer the technology known as "MRA Fusion" to treat uterine fibroids. For this work, Dr. Gupta was recognized by rt Image magazine as among the 25 most influential people/events in the field of radiology. Dr. Gupta was listed third, following only Healthcare Reform and radiology efforts in the wake of the Haiti earthquake.

"Sometimes X-rays are necessary during medical procedures so we can guide our tiny instruments through the arteries to the point of disease," he explains. "Yet this is actually a kind of double-edged sword. We are doing a better job, but the patient is being exposed to higher doses of radiation."

The system combines patient images from multiple modalities like MRI and CT scan to create a real-time 3-D map that displays the instrument position, orientation, and trajectory, as well as anatomical landmarks. This 'map' helps to guide physicians to areas of interest, even when they are small, hard to visualize, difficult to access, or close to sensitive organs, vessels, or tissue.

Dr. Gupta says, "With these sophisticated computers I can make a 'roadmap' using the patient's existing CT scan or MRI data. The technology virtually fuses the scan to an image of the patient on the procedure table. As a result, I can do the procedure faster. Preliminary studies show that we also use far less radiation, and the procedure also usually offers an alternative to hysterectomy. We are performing surgery of the future."


'/>"/>
SOURCE Main Line Health
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Institut Paoli Calmettes and Ipsogen Presented a New Study Supporting the Pivotal Role of Tumor Grade in Chemotherapy Prescription at the 32nd Annual San Antonio Breast Cancer Symposium
2. Baylor College of Medicine and Texas Childrens Hospital Neuroscientist Dr. Huda Zoghbi Awarded Gruber Neuroscience Prize
3. Hospital for Special Surgery to Host International Arthritis Summit: Frontiers in Osteoarthritis Research, Prevention and Care
4. St. Lukes Hospital & Health Network Selects CareTech Solutions to Provide Proactive Monitoring of Hospital IT Infrastructure
5. BioNeutral to Premier its EPA-Approved Ygiene® 206 Hospital-Grade Disinfectant at the Annual 2011 APIC Conference, While Community Health of South Florida Begins Product Review
6. SynapDx Corporation Licenses Autism Diagnostic Discoveries From Childrens Hospital Boston
7. Newly Published Study Shows Dramatic Reduction in Hospital Acquired Infections
8. WARFARIN Study Launched at WellStar Health System to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin
9. WARFARIN Study Launched at Overlake Hospital Medical Center to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin
10. Zimmer Helps Physicians and Hospitals Negotiate Emerging Health Care Business Challenges Through New Consulting Programs
11. Four Community Hospitals Join DNA Directs Genomic Medicine Network
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... ... Scientists at the University of Athens say they have evidence that the variety ... that could lead to one good one. Surviving Mesothelioma has just posted an article ... team evaluated 98 mesothelioma patients who got a second kind of drug ...
(Date:5/25/2016)... ... May 25, 2016 , ... Biohaven Pharmaceutical Holding Company Ltd. ... the company’s orphan drug designation request covering BHV-4157 for the treatment of Spinocerebellar ... FDA. , Spinocerebellar ataxia is a rare, debilitating neurodegenerative disorder that is ...
(Date:5/24/2016)... ... May 24, 2016 , ... Last week, Callan Capital, ... executives and entrepreneurs, held The Future of San Diego Life Science event at the ... life science community attended the event with speakers Dr. Rich Heyman, former CEO of ...
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® Media has released ... and Beyond. The paper outlines the key trends that are creating both opportunities ... witnessed a lot of highs and lows as the precision agriculture market has ...
Breaking Biology Technology:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):